EFFICACY OF TELAPREVIR DOSED TWICE DAILY VERSUS EVERY 8 HOURS BY IL28B GENOTYPE: RESULTS FROM THE PHASE III OPTIMIZE STUDY

被引：4

作者：

Buti, M. ^{[1
,2
]}

Agarwal, K. ^{[3
]}

Horsmans, Y. ^{[4
]}

Sievert, W. ^{[5
,6
]}

Janczewska, E. ^{[7
]}

Zeuzem, S. ^{[8
]}

Nyberg, L. ^{[9
]}

Brown, R. S., Jr. ^{[10
]}

Hezode, C. ^{[11
]}

Rizzetto, M. ^{[12
]}

Parana, R. ^{[13
]}

De Meyer, S. ^{[14
]}

DeMasi, R. ^{[15
]}

Luo, D. ^{[15
]}

Witek, J. ^{[15
]}

机构：

[1] Hosp Gen Valle Hebron, Barcelona, Spain

[2] Ciberehd, Inst Carlos 3, Barcelona, Spain

[3] Kings Coll Hosp London, London, England

[4] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium

[5] Monash Med Ctr, Melbourne, Vic, Australia

[6] Monash Univ, Melbourne, Vic 3004, Australia

[7] Outpatients Clin Hepatol, Myslowice, Poland

[8] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany

[9] Kaiser Permanente, San Diego, CA USA

[10] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA

[11] Hop Henri Mondor, F-94010 Creteil, France

[12] Univ Turin, Turin, Italy

[13] Univ Fed Bahia, Sch Med, BR-41170290 Salvador, BA, Brazil

[14] Janssen Infect Dis BVBA, Beerse, Belgium

[15] Janssen Res & Dev LLC, Titusville, NJ USA

来源：

关键词：

D O I：

10.1016/S0168-8278(13)60800-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

798

引用

页码：S326 / S326

页数：1